Hello and Welcome to Patientsville.com, Your Source for all METHYLDOPA information. We are dedicated to provide You with METHYLDOPA safety information. Learn about METHYLDOPA serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
METHYLDOPA Safety Reports
Total METHYLDOPA reports: 8.METHYLDOPA FDA safety alerts: No.
Reported hospitalizations: 3.
Take METHYLDOPA Side Effects Survey or Share Your METHYLDOPA Story. Read More Here.
Consumer or non-health professional from CANADA reported METHYLDOPA problem on Dec 29, 2006. Female patient, 58 years of age, weighting 240.3 lb, was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dehydration, hypertension, hypertensive crisis, thrombocytopenia. METHYLDOPA dosage: unknown. Patient was hospitalized. Patient recovered.
METHYLDOPA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 17, 2006. Female patient, 58 years of age, was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. METHYLDOPA dosage: 500 MG (250 MG, 2 IN 1 D), ORAL. Patient recovered.
Physician from UNITED STATES reported METHYLDOPA problem on June 27, 2007. Female patient, 28 years of age, was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood pressure increased, hepatitis c positive, liver disorder. METHYLDOPA dosage: unknown. Patient recovered.
METHYLDOPA problem was reported by a Physician from UNITED STATES on Sept 01, 2006. Female patient, weighting 183.0 lb, was diagnosed with hypertension and was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: hepatitis acute. METHYLDOPA dosage: 250 MG TWICE DAILY ORAL. Patient recovered.
Physician from JAPAN reported METHYLDOPA problem on Oct 02, 2006. Male patient was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: caesarean section, congenital cytomegalovirus infection, cyst, deafness neurosensory, dilatation ventricular, hypokinesia neonatal, neonatal disorder. METHYLDOPA dosage: unknown. Patient was hospitalized. Patient recovered.
METHYLDOPA problem was reported by a Health Professional from UNITED STATES on Oct 23, 2006. Female patient, 42 years of age, weighting 130.0 lb, was diagnosed with hypertension and was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: headache, palpitations. METHYLDOPA dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported METHYLDOPA problem on Oct 18, 2006. Female patient, 58 years of age, weighting 240.3 lb, was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dehydration, hypertension. METHYLDOPA dosage: unknown. Patient was hospitalized. Patient recovered.
METHYLDOPA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2007. Female patient, weighting 220.0 lb, was diagnosed with eclampsia, hypertension and was treated with METHYLDOPA. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, faeces pale, hepatic enzyme increased, ocular icterus, urine colour abnormal, yellow skin. METHYLDOPA dosage: 500 MG 2 DAILY PO. Patient recovered.